Vanzacaftor
VX22-121-013
Phase 1 small_molecule completed
Quick answer
Vanzacaftor for Cystic Fibrosis is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Cystic Fibrosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed